Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles.
Kim JS, Kim MW, Kang SJ, Jeong HY, Park SI, Lee YK, Kim HS, Kim KS, Park YS.
Kim JS, et al. Among authors: kim ks, kim mw, kim hs.
Int J Nanomedicine. 2018 Aug 27;13:4817-4830. doi: 10.2147/IJN.S161932. eCollection 2018.
Int J Nanomedicine. 2018.
PMID: 30214190
Free PMC article.